Dermata Therapeutics, Inc. (DRMA)

NASDAQ

$0.79

$+0.25

(+37.95%)

Regular Market

Dermata Therapeutics, Inc. (DRMA) Live Price Chart

Last updated: ⁦2026-10-15 13:52:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Dermata Therapeutics, Inc. (DRMA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.79, with a market capitalisation of $4.26M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.60 to $4.66. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$4.26M
Open	$0.77
Day's High	$16,680.00
Day's Low	$0.60
Previous Close	$0.66
Volume	75.04M
Average Volume	721.10K
P/E Ratio	--
52-Week High	$4.66
52-Week Low	$0.60
Dividend Yield	--
Earnings Date	--

Dermata Therapeutics, Inc. (DRMA) Stock Price Today

Dermata Therapeutics, Inc. (DRMA) is currently trading at $0.79 as of 2026-10-15 13:36:55, up 19.40% ($0.13) from the previous close of $0.66

During today's regular trading session, DRMA has traded between $0.60 and $16,680.00, with a trading volume of 75.04M shares. The current price is near the lower end of today's range.

Dermata Therapeutics, Inc. (DRMA) 7-Day Stock Price Change

Over the past seven days, Dermata Therapeutics, Inc. (DRMA) moved from $1.13 to $0.79, representing a decline of 29.91% ($0.34).

The stock traded between $0.60 and $1.15 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.

The average daily volume was 71.77 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

DRMA 52-Week Price Position

Position in Range: 4.7%

52W Low$0.60

52W High$4.66

DRMA is currently trading at $0.79, placing it 4.7% of the way from its 52-week low of $0.60 to its 52-week high of $4.66. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Dermata Therapeutics, Inc. (DRMA)?

Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions. It focuses on leveraging prior clinical and technical expertise to develop OTC treatments for conditions such as acne, psoriasis, rosacea, and seborrheic dermatitis. The company is currently developing a once-weekly acne treatment system that utilizes an active ingredient from the OTC monograph in combination with the company's Spongilla technology. It intends to apply its Spongilla technology platform across a range of dermatologic and aesthetic skin applications, including intradermal delivery of botulinum toxin. The company's operates in one segment, which is the business of developing, branding, marketing, and commercializing direct to consumer skincare products.

Dermata Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	9
Exchange	NASDAQ
Company Website	https://www.dermatarx.com

How to Buy Dermata Therapeutics, Inc. (DRMA) Stock on MEXC

Eligible investors can buy real shares of Dermata Therapeutics, Inc. (DRMA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for DRMA and Place Your Order

Open the RealStocks trading page and search for DRMA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Dermata Therapeutics, Inc. (DRMA) stock price today?

Dermata Therapeutics, Inc. (DRMA) is currently trading at $ 0.79, up 19.40% ($0.13) from the previous close of $ 0.66. Intraday prices update in real time during regular trading hours.

2.Is DRMA stock going up or down today?

As of 2026-10-15 13:36:55, DRMA is trading at $ 0.79, up 19.40% ($0.13) from its previous close of $ 0.66. The stock has traded between $ 0.60 and $ 16,680.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is DRMA pre-market price?

As of 2026-10-15 13:36:55, DRMA is trading at $ 0.76 in pre-market trading, up 15.18% ($0.10) from the previous close of $ 0.66. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is DRMA after-hours price?

As of 2026-10-15 13:36:55, DRMA is trading at $ 0.69 in after-hours trading, up 3.57% ($0.02) from the regular-session close of $ 0.66. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is DRMA stock trading now?

DRMA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does DRMA sit relative to its 52-week high and low?

Over the past 52 weeks, DRMA has traded between a low of $ 0.60 and a high of $ 4.66. At $ 0.79, the stock is positioned 4.7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Dermata Therapeutics, Inc. in?

Dermata Therapeutics, Inc. (DRMA) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Dermata Therapeutics, Inc.'s market capitalisation and where is it listed?

Dermata Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 4.26M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is DRMA valued in terms of P/E ratio and EPS?

DRMA trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.69. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Dermata Therapeutics, Inc. pay a dividend?

Dermata Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.